REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Frontier Biotechnologies Inc. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Frontier Biotechnologies Inc. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Frontier Biotechnologies Inc. focuses on the R&D, production and sales of innovative drugs with significant clinical needs. The company provides original anti AIDS drugs. The company was established in 2013 and headquartered in Nanjing City, China.

Headquarters
11th Floor, Building E-2, Greenland Window, Dongshan Street, Jiangning District, Nanjing City, Jiangsu Province
Nanjing; Jiangsu; Postal Code: 211199

Contact Details: Purchase the Frontier Biotechnologies Inc. report to view the information.

Website: http://www.frontierbiotech.com

Basic Information
Total Employees:
Purchase the Frontier Biotechnologies Inc. report to view the information.
Outstanding Shares:
Purchase the Frontier Biotechnologies Inc. report to view the information.
Registered Capital:
Purchase the Frontier Biotechnologies Inc. report to view the information.
Financial Auditors:
Purchase the Frontier Biotechnologies Inc. report to view the information.
Incorporation Date:
January 15, 2013
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Chief Operating Officer
Ownership Details
Purchase this report to view the information.
18.86%
Purchase this report to view the information.
5.8%
Purchase this report to view the information.
5.62%
Purchase this report to view the information.
4.59%
Purchase this report to view the information.
3.72%
Subsidiaries
Beijing Frontier Jiahe Biotechnology Co., Ltd.
100%
Dezhou Frontier Bio-Environmental Protection Technology Co., Ltd.
100%
Frontier Biopharmaceuticals (Hong Kong) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Frontier Biotechnologies Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
26.9%▲
Total operating revenue
22.36%▲
Operating profit (EBIT)
19.98%▲
Net Profit (Loss) for the Period
20.21%▲
Total assets
-8.9%▼
Total equity
-19.59%▼
Operating Profit Margin (ROS)
123.5%▲
Net Profit Margin
124.64%▲
Return on Equity (ROE)
0.14%▲
Debt to Equity Ratio
6.8%▲
Quick Ratio
-1.53%▼
Cash Ratio
-2.14%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shenzhen Guohua Network Security Technology Co., Ltd.
 
Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港))
Dali Pharmaceutical Co., Ltd
 
Kunming Longjin Pharmaceutical Co., Ltd.
Broncus Holding Corporation (Hong Kong) (Broncus Holding Corporation (香港))
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo